Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.10.1 extracted from

  • Lu, Y.; Yao, H.P.; Wang, M.H.
    Multiple variants of the RON receptor tyrosine kinase: Biochemical properties, tumorigenic activities, and potential drug targets (2007), Cancer Lett., 257, 157-164.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
PF-2341066 IC50: 0.002 mM Homo sapiens
PHA-665752 IC50: 0.0009 mM Homo sapiens

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
40000
-
1 * 145000 + 1 * 40000 Homo sapiens
145000
-
1 * 145000 + 1 * 40000 Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
breast cancer cell
-
Homo sapiens
-
colonic cancer cell
-
Homo sapiens
-
lung adenocarcinoma cell
-
Homo sapiens
-
pancreatic cancer cell
-
Homo sapiens
-
skin cancer cell
-
Homo sapiens
-
thyroid cancer cell
-
Homo sapiens
-
urinary bladder cancer cell
-
Homo sapiens
-

Subunits

Subunits Comment Organism
heterodimer 1 * 145000 + 1 * 40000 Homo sapiens

Synonyms

Synonyms Comment Organism
RON receptor tyrosine kinase
-
Homo sapiens
Stem cell-derived tyrosine kinase
-
Homo sapiens
STK
-
Homo sapiens

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0009
-
IC50: 0.0009 mM Homo sapiens PHA-665752
0.002
-
IC50: 0.002 mM Homo sapiens PF-2341066